NIIN Output Data
NIIN:
NSN:
Item Name:
TETRACYCLINE HYDROCHLORIDE CAPSU
Definition:
Reference/Part Number
Part Number | CAGE | Status | RNCC | RNVC | DAC | RNAAC | MSDS | SADC |
---|---|---|---|---|---|---|---|---|
17153 | 63488 | A | 3 | 2 | 6 | 54 | ||
17163 | 63488 | A | 3 | 2 | 6 | 54 | ||
ACHROMYCIN V CAPSULES | 06404 | A | 5 | 1 | 6 | 54 | ||
NDC00003-0655-60 | 78473 | F | 5 | 9 | 6 | 54 | ||
PANMYCIN | 93703 | A | 5 | 1 | 4 | KX | ||
NDC00378-0101-10 | 60895 | A | 5 | 2 | 4 | ZZ | ||
NDC00047-0407-32 | 91378 | A | 5 | 9 | 4 | ZZ | ||
NDC00009-0782-03 | 93703 | A | 5 | 9 | 6 | 54 | ||
NDC00781-2529-10 | 59043 | F | 5 | 9 | 6 | 54 | ||
NDC00536-1820-10 | 4V824 | H | 5 | 9 | 6 | 54 | ||
NDC00378-0101-10 | 0A423 | A | 5 | 2 | 4 | ZZ | ||
SUMSYCIN | 78473 | F | 5 | 9 | 4 | KX | ||
NDC00115-1401-03 | 59352 | F | 5 | 9 | 6 | 54 | ||
SUMSYCIN CAPSULES | 78473 | F | 5 | 9 | 6 | 54 | ||
NDC00364-2026-02 | 0PTT8 | A | 5 | 2 | 4 | ZZ | ||
NDC00115-1405-03 | 59352 | F | 5 | 9 | 6 | 54 | ||
PANMYCIN CAPSULES | 93703 | A | 5 | 1 | 6 | 54 | ||
NDC00879-0158-10 | 60964 | A | 3 | 2 | 6 | 54 | ||
ACHROMYCIN V | 06404 | A | 5 | 1 | 4 | KX | ||
655 | 78473 | F | 5 | 9 | 6 | 54 | ||
NDC00003-0655-60 | 1M8G6 | A | 5 | 9 | 5 | ZZ | ||
NDC00005-4880-34 | 06404 | A | 3 | 2 | 6 | 54 |
CAGE Information
Code | Company |
---|---|
06404 | AMERICAN CYANAMID CO LEDERLE LABORAT |
63488 | GOLDLINE LABORATORIES INC. DBA GOLDL |
78473 | SQUIBB E R AND SONS INC WORLD HQ |
93703 | PHARMACIA & UPJOHN COMPANY |
60895 | MYLAN PHARMACEUTICALS INC |
91378 | PARKE-DAVIS DIV OF WARNER-LAMBERT CO |
59043 | GENEVA PHARMACEUTICALS INC |
4V824 | RUGBY GROUP INC |
0A423 | CARDINAL HEALTH 100 INC DBA BINDLEY |
59352 | RICHLYN LABORATORIES INC |
0PTT8 | SCHEIN PHARMACEUTICAL INC |
60964 | HALSEY DRUG CO INC |
1M8G6 | BRISTOL-MYERS SQUIBB COMPANY DBA BRI |
Federal Supply Class
Title
DRUGS AND BIOLOGICALS
Inclusions:
INCLUDES ALL DRUGS, MEDICINAL GRADE CHEMICALS, AND BIOLOGICALS SUBJECT TO THE FEDERAL FOOD, DRUG AND COSMETIC ACT, LISTED IN THE MONOGRAPH SECTION OF THE U.S. PHARMACOPEIA OR THE NATIONAL FORMULARY OR COVERED BY THE UNITED STATES ADOPTED NAMES (USAN). OTHER NATIONS MAY APPLY THEIR OWN LEGAL DOCUMENTS.
Exclusions:
EXCLUDES MEDICATED COSMETICS AND TOILETRIES CLASSIFIABLE IN FSC 6508 AND IN VITRO DIAGNOSTIC SUBSTANCES AND REAGENTS CLASSIFIABLE IN FSC 6550, AND VETERINARY DRUGS AND BIOLOGICALS CLASSIFIABLE IN FSC 6509.
Characteristics (Decoded)
MRC | Requirements Statement | Clear Text Reply |
---|---|---|
CQLS | CAPSULE CONTENT FORM | ANY ACCEPTABLE |
SUCB | UNIT OF ISSUE CUBE | 0.067 CUBIC FEET |
EXME | EXTERIOR CONTAINER CUBIC MEASURE | 0.671 CUBIC FEET |
CQCT | PRIMARY CONTAINER TYPE | BOTTLE |
EXQT | EXTERIOR CONTAINER QUANTITY | 10 |
ECWT | EXTERIOR CONTAINER WEIGHT | 13.00 POUNDS |
AKJC | CAPSULE TYPE | ANY ACCEPTABLE |
AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 250.000 MILLIGRAMS TETRACYCLINE HYDROCHLORIDE ACTIVE INGREDIENT |
CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | TETRACYCLINE HYDROCHLORIDE CAPSULES USP 250MG 1000S BT |
SUWT | UNIT OF ISSUE WEIGHT | 0.13 POUNDS |
CYLZ | CAPSULE PRIMARY CONTAINER CONTENT QUANTITY | 1000.000 |
Similar Parts
ACHROMYCIN V ,
ACHROMYCINV ,
6505-00-963-4924 ,
6505009634924 ,
009634924
,
17153 ,
17163 ,
ACHROMYCIN V CAPSULES ,
NDC00003-0655-60 ,
PANMYCIN ,
NDC00378-0101-10 ,
NDC00047-0407-32 ,
NDC00009-0782-03 ,
NDC00781-2529-10 ,
NDC00536-1820-10 ,
NDC00378-0101-10 ,
SUMSYCIN ,
NDC00115-1401-03 ,
SUMSYCIN CAPSULES ,
NDC00364-2026-02 ,
NDC00115-1405-03 ,
PANMYCIN CAPSULES ,
NDC00879-0158-10 ,
ACHROMYCIN V ,
655 ,
NDC00003-0655-60 ,
NDC00005-4880-34 ,